Bard Boosts R&D, Scans Acquisition Targets To Buck Historical Growth Trend
This article was originally published in The Gray Sheet
Executive Summary
Bard will draw on $463 mil. in cash and short-term investments to support an aggressive business development strategy aimed at raising top-line revenue beyond its traditional 7%-10% annual growth rate
You may also be interested in...
Mid-Sized Bard Delivers Solid Growth In Device Landscape Of Giants, Infants
Bard aims to rely on execution in niche areas where it can comfortably sustain market leadership to deliver sustainable double-digit revenue growth, according to President & CEO Tim Ring
Mid-Sized Bard Delivers Solid Growth In Device Landscape Of Giants, Infants
Bard aims to rely on execution in niche areas where it can comfortably sustain market leadership to deliver sustainable double-digit revenue growth, according to President & CEO Tim Ring
Bard Vascular Unit To Do Heavy Lifting As Hernia Sales Growth Slows
Bard is reevaluating its programmable pain pump strategy due to developmental delays caused by imaging technology compatibility issues